CytomX Therapeutics
CTMX
₹212.24
Share price
5.08%
Change (1 day)
92.58%
Change (1 year)
Categories
CytomX Therapeutics (CTMX) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : ₹6.28 Billion
According to CytomX Therapeutics 's latest financial reports the company's total liabilities are ₹6.28 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
CytomX Therapeutics - Total liabilities on balance sheet (from 2014 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | ₹10.37 B | -49.98% |
| 2023-12-31 | ₹20.74 B | -27.67% |
| 2022-12-31 | ₹28.68 B | 13.39% |
| 2021-12-31 | ₹25.29 B | -5.6% |
| 2020-12-31 | ₹26.79 B | 29.51% |
| 2019-12-31 | ₹20.69 B | -9.29% |
| 2018-12-31 | ₹22.81 B | 9% |
| 2017-12-31 | ₹20.92 B | 155.25% |
| 2016-12-31 | ₹8.19 B | 73.4% |
| 2015-12-31 | ₹4.72 B | -50.79% |
| 2014-12-31 | ₹9.60 B | 166.03% |
| 2013-12-31 | ₹3.61 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | ₹1.97 B | -68.52% | 🇺🇸 USA |